Table 2 The RQS scale for the included studies
Study | Image protocol | Multiple segmentations | Phantom study | Multiple time points | Feature reduction | Non-radiomics | Biological correlates | Cut-off | Discrimination | Calibration | Prospective | Validation | Gold standard | Clinical utility | Cost | Open Science | Total score (-8-36) | Percentage(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sui | 1 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 0 | 0 | 11 | 30.6 |
Wang | 1 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | -5 | 2 | 0 | 0 | 0 | 1 | 2.8 |
Chen | 1 | 1 | 0 | 0 | 3 | 1 | 0 | 1 | 1 | 1 | 0 | 4 | 2 | 2 | 0 | 0 | 17 | 47.2 |
Ren | 1 | 1 | 0 | 0 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 2 | 2 | 0 | 0 | 13 | 36.1 |
Hu | 1 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | -5 | 2 | 0 | 0 | 0 | 2 | 5.6 |
Xiao | 1 | 0 | 0 | 0 | 3 | 1 | 0 | 0 | 1 | 1 | 0 | 2 | 2 | 2 | 0 | 0 | 13 | 36.1 |
Blüthgen | 1 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | -5 | 2 | 0 | 0 | 0 | 2 | 5.6 |
Dong | 1 | 1 | 0 | 0 | 3 | 1 | 0 | 0 | 0 | 1 | 0 | 2 | 2 | 2 | 0 | 0 | 13 | 36.1 |
Yu | 1 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 2 | 2 | 0 | 0 | 11 | 30.6 |
Araujo-Filho | 1 | 1 | 0 | 0 | 3 | 0 | 0 | 1 | 0 | 0 | 2 | 2 | 0 | 0 | 0 | 10 | 27.8 | |
Tian | 1 | 1 | 0 | 0 | 3 | 1 | 0 | 0 | 2 | 1 | 0 | 2 | 2 | 0 | 0 | 0 | 13 | 36.1 |
Feng | 1 | 1 | 0 | 0 | 3 | 1 | 0 | 0 | 1 | 0 | 0 | 2 | 2 | 0 | 0 | 0 | 11 | 30.6 |
Nakajo | 1 | 1 | 0 | 0 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | -5 | 2 | 0 | 0 | 0 | 3 | 8.3 |
Sui | 1 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 0 | 0 | 11 | 30.6 |